标题
A review of possible therapies for multiple sclerosis
作者
关键词
-
出版物
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-04-22
DOI
10.1007/s11010-021-04119-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Gene Therapy Approaches in an Autoimmune Demyelinating Disease: Multiple Sclerosis
- (2020) Md Asiful Islam et al. CURRENT GENE THERAPY
- Therapeutic plasma exchange may adjust IL‐6 and TGF‐β signals in relapsed MS patients peripheral blood
- (2020) Azam Jamshidian et al. JOURNAL OF CLINICAL APHERESIS
- Functional activity of anti-LINGO-1 antibody opicinumab requires target engagement at a secondary binding site
- (2020) Karl J. M. Hanf et al. mAbs
- Gene Therapy with Single-Subunit Yeast NADH-Ubiquinone Oxidoreductase (NDI1) Improves the Visual Function in Experimental Autoimmune Encephalomyelitis (EAE) Mice Model of Multiple Sclerosis (MS)
- (2020) Venu Talla et al. MOLECULAR NEUROBIOLOGY
- Haematopoietic Stem Cell Transplantation for Multiple Sclerosis: Current Status
- (2020) Alice Mariottini et al. BIODRUGS
- Neuroprotective effects of exercise in people with progressive multiple sclerosis (Exercise PRO-MS): study protocol of a phase II trial
- (2020) A. S. Gravesteijn et al. BMC Neurology
- Metformin Enhances Autophagy and Normalizes Mitochondrial Function to Alleviate Aging-Associated Inflammation
- (2020) Leena P. Bharath et al. Cell Metabolism
- Matching-adjusted comparisons demonstrate better clinical outcomes in patients with relapsing multiple sclerosis treated with peginterferon beta-1a than with teriflunomide
- (2020) Scott D. Newsome et al. Multiple Sclerosis and Related Disorders
- Mitochondrial Oxidative Damage Underlies Regulatory T Cell Defects in Autoimmunity
- (2020) Themis Alissafi et al. Cell Metabolism
- Monoclonal Antibodies for Multiple Sclerosis: An Update
- (2019) Jonas Graf et al. BIODRUGS
- B cell depletion in the treatment of multiple sclerosis
- (2019) Kjell-Morten Myhr et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis
- (2019) Tomas Kalincik et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Association of Rituximab Treatment With Disability Progression Among Patients With Secondary Progressive Multiple Sclerosis
- (2019) Yvonne Naegelin et al. JAMA Neurology
- Immunoadsorption or plasma exchange in steroid-refractory multiple sclerosis and neuromyelitis optica
- (2019) Mark Lipphardt et al. JOURNAL OF CLINICAL APHERESIS
- Association of circulating anti-CD64 IgM levels with favourable long-term clinical outcomes in multiple sclerosis patients
- (2019) Pasquale Annunziata et al. JOURNAL OF NEUROIMMUNOLOGY
- Therapeutic Plasma Exchange in Tehran Between 2011 and 2014
- (2019) Azita Chegini et al. THERAPEUTIC APHERESIS AND DIALYSIS
- High Glucose Intake Exacerbates Autoimmunity through Reactive-Oxygen-Species-Mediated TGF-β Cytokine Activation
- (2019) Dunfang Zhang et al. IMMUNITY
- Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing
- (2019) Lana Zhovtis Ryerson et al. NEUROLOGY
- The potential use of mesenchymal stem cells for the treatment of multiple sclerosis
- (2019) Sahar Rostami Mansoor et al. LIFE SCIENCES
- A retrospective cohort study of plasma exchange in central nervous system demyelinating events in children
- (2019) Michael Manguinao et al. Multiple Sclerosis and Related Disorders
- Siponimod Chips Away at Progressive MS
- (2019) Erin E. Longbrake et al. CELL
- Comparing Plasma Exchange to Escalated Methyl Prednisolone in Refractory Multiple Sclerosis Relapses
- (2019) Steffen Pfeuffer et al. Journal of Clinical Medicine
- Increased HLA-DR expression and cortical demyelination in MS links with HLA-DR15
- (2019) Lukas Simon Enz et al. Neurology-Neuroimmunology & Neuroinflammation
- Human miR-26a-5p regulates the glutamate transporter SLC1A1 (EAAT3) expression. Relevance in multiple sclerosis
- (2018) Nicoletta Potenza et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Alemtuzumab for the treatment of multiple sclerosis
- (2018) Jennifer R. Evan et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Safe and effective interferon-beta gene therapy for the treatment of multiple sclerosis by regulating biological activity through the design of interferon-beta-galectin-9 fusion proteins
- (2018) Atsushi Hamana et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Monitoring and management of autoimmunity in multiple sclerosis patients treated with alemtuzumab: practical recommendations
- (2018) Virginia Devonshire et al. JOURNAL OF NEUROLOGY
- Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
- (2018) Ludwig Kappos et al. LANCET
- Beneficial Effects of the Calcium Channel Blocker CTK 01512-2 in a Mouse Model of Multiple Sclerosis
- (2018) Rodrigo B. M. Silva et al. MOLECULAR NEUROBIOLOGY
- Gene Therapy-Induced Antigen-Specific Tregs Inhibit Neuro-inflammation and Reverse Disease in a Mouse Model of Multiple Sclerosis
- (2018) Geoffrey D. Keeler et al. MOLECULAR THERAPY
- Volatile compounds emission from teratogenic human pluripotent stem cells observed during their differentiation in vivo
- (2018) Rosamaria Capuano et al. Scientific Reports
- Alemtuzumab as Treatment for Multiple Sclerosis
- (2018) Serafeim Katsavos et al. Cold Spring Harbor Perspectives in Medicine
- Cell Transplantation for Spinal Cord Injury: Tumorigenicity of Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cells
- (2018) Junhao Deng et al. Stem Cells International
- Interleukin-27 Gene Therapy Prevents the Development of Autoimmune Encephalomyelitis but Fails to Attenuate Established Inflammation due to the Expansion of CD11b+Gr-1+ Myeloid Cells
- (2018) Jianmin Zhu et al. Frontiers in Immunology
- A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future
- (2018) Mehrdad Gholamzad et al. INFLAMMATION RESEARCH
- Cutting Edge: TGF-β and Phosphatidylinositol 3-Kinase Signals Modulate Distinct Metabolism of Regulatory T Cell Subsets
- (2018) Bhavana Priyadharshini et al. JOURNAL OF IMMUNOLOGY
- Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis
- (2018) Tanuja Chitnis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glutathione de novo synthesis but not recycling process coordinates with glutamine catabolism to control redox homeostasis and directs murine T cell differentiation
- (2018) Gaojian Lian et al. eLife
- Sarcoidosis following alemtuzumab treatment for multiple sclerosis
- (2018) Mark D Willis et al. Multiple Sclerosis Journal
- Intrathecal treatment trial of rituximab in progressive MS
- (2018) Joakim Bergman et al. NEUROLOGY
- The retinoprotective role of phenytoin
- (2018) Silvia Bartollino et al. Drug Design Development and Therapy
- Selective Ablation of Tumorigenic Cells Following Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in Spinal Cord Injury
- (2018) Kota Kojima et al. Stem Cells Translational Medicine
- Daclizumab for the treatment of relapsing-remitting multiple sclerosis
- (2017) Marina Herwerth et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Epigenetic and gene expression alterations of FOXP3 in the T cells of EAE mouse model of multiple sclerosis
- (2017) Ali Noori-Zadeh et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial
- (2017) Ari J Green et al. LANCET
- Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial
- (2017) Diego Cadavid et al. LANCET NEUROLOGY
- Interleukin 35 and Hepatocyte Growth Factor; as a novel combined immune gene therapy for Multiple Sclerosis disease
- (2017) Samira Moghadam et al. MEDICAL HYPOTHESES
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of flu-like syndrome with cetirizine in patients with relapsing-remitting multiple sclerosis during therapy with interferon beta: Results of a randomized, cross-over, placebo-controlled pilot study
- (2017) Doriana Landi et al. PLoS One
- Oral teriflunomide in the treatment of relapsing forms of multiple sclerosis: clinical evidence and long-term experience
- (2017) Aaron E. Miller Therapeutic Advances in Neurological Disorders
- Lesion remyelinating activity of GSK239512 versus placebo in patients with relapsing-remitting multiple sclerosis: a randomised, single-blind, phase II study
- (2016) Caryl J. Schwartzbach et al. JOURNAL OF NEUROLOGY
- Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial
- (2016) Rhian Raftopoulos et al. LANCET NEUROLOGY
- Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis
- (2016) Mansoureh Togha et al. MOLECULAR NEUROBIOLOGY
- MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
- (2016) Ayman Tourbah et al. Multiple Sclerosis Journal
- Epigenetic Modifications and Therapy in Multiple Sclerosis
- (2016) Saeed Aslani et al. NEUROMOLECULAR MEDICINE
- Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis
- (2016) Frédéric Sedel et al. NEUROPHARMACOLOGY
- Comparison of a teratogenic transcriptome-based predictive test based on human embryonic versus inducible pluripotent stem cells
- (2016) Vaibhav Shinde et al. Stem Cell Research & Therapy
- Survival and Functionality of Human Induced Pluripotent Stem Cell-Derived Oligodendrocytes in a Nonhuman Primate Model for Multiple Sclerosis
- (2016) Arun Thiruvalluvan et al. Stem Cells Translational Medicine
- MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
- (2016) Ayman Tourbah et al. Multiple Sclerosis Journal
- Multiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem Cells
- (2016) Megan G. Massa et al. PLoS One
- Humanized Mice Reveal Differential Immunogenicity of Cells Derived from Autologous Induced Pluripotent Stem Cells
- (2015) Tongbiao Zhao et al. Cell Stem Cell
- Ion Channel Modulation as a Therapeutic Approach in Multiple Sclerosis
- (2015) R. Arnold et al. CURRENT MEDICINAL CHEMISTRY
- Advances in the immunopathogenesis of multiple sclerosis
- (2015) Sudhir K. Yadav et al. CURRENT OPINION IN NEUROLOGY
- Treatment of progressive multifocal leukoencephalopathy–immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab
- (2015) Z. Calic et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis
- (2015) Maria A Rocca et al. LANCET NEUROLOGY
- Treatment of progressive multiple sclerosis: what works, what does not, and what is needed
- (2015) Anthony Feinstein et al. LANCET NEUROLOGY
- Role of the innate and adaptive immune responses in the course of multiple sclerosis
- (2015) Bernhard Hemmer et al. LANCET NEUROLOGY
- Multiple Sclerosis
- (2014) Daniel M. Harrison ANNALS OF INTERNAL MEDICINE
- Management and prognosis of multiple sclerosis
- (2014) Ghaniah Hassan-Smith et al. BRITISH JOURNAL OF HOSPITAL MEDICINE
- CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis
- (2014) Yaniv Zohar et al. JOURNAL OF CLINICAL INVESTIGATION
- Multiple Sclerosis: Current and Emerging Disease-Modifying Therapies and Treatment Strategies
- (2014) Dean M. Wingerchuk et al. MAYO CLINIC PROCEEDINGS
- Fine Structure of Neurally Differentiated iPS Cells Generated from a Multiple Sclerosis (MS) Patient: A Case Study
- (2014) Daniella Herszfeld et al. MICROSCOPY AND MICROANALYSIS
- Pervasive Axonal Transport Deficits in Multiple Sclerosis Models
- (2014) Catherine Diamante Sorbara et al. NEURON
- Modulation of oxidative stress, apoptosis, and calcium entry in leukocytes of patients with multiple sclerosis byHypericum perforatum
- (2014) Mustafa Naziroglu et al. NUTRITIONAL NEUROSCIENCE
- Efficient Generation of Myelinating Oligodendrocytes from Primary Progressive Multiple Sclerosis Patients by Induced Pluripotent Stem Cells
- (2014) Panagiotis Douvaras et al. Stem Cell Reports
- Oligodendrogenesis from neural stem cells: Perspectives for remyelinating strategies
- (2013) Sofia Grade et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
- A regenerative approach to the treatment of multiple sclerosis
- (2013) Vishal A. Deshmukh et al. NATURE
- Regulatory T cell proliferative potential is impaired in human autoimmune disease
- (2013) Fortunata Carbone et al. NATURE MEDICINE
- Metallothioneins negatively regulate IL-27-induced type 1 regulatory T-cell differentiation
- (2013) C. Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation
- (2012) Peter J. Darlington et al. ANNALS OF NEUROLOGY
- Sudden unexpected death on fingolimod
- (2012) JW Lindsey et al. Multiple Sclerosis Journal
- Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models
- (2012) Lianhua Bai et al. NATURE NEUROSCIENCE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis
- (2011) Madhan Thamilarasan et al. AUTOIMMUNITY REVIEWS
- Immunopathogenesis of multiple sclerosis
- (2011) Manuel Comabella et al. CLINICAL IMMUNOLOGY
- Differentiation of induced pluripotent stem cells into functional oligodendrocytes
- (2011) Marcin Czepiel et al. GLIA
- Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
- (2011) R. D. Michalek et al. JOURNAL OF IMMUNOLOGY
- Glatiramer acetate antibodies, gene expression and disease activity in multiple sclerosis
- (2011) F Sellebjerg et al. Multiple Sclerosis Journal
- Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
- (2011) Paul O'Connor et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA-155 Promotes Autoimmune Inflammation by Enhancing Inflammatory T Cell Development
- (2010) Ryan M. O'Connell et al. IMMUNITY
- Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
- (2010) Raju Kapoor et al. LANCET NEUROLOGY
- Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
- (2010) J. J. Marriott et al. NEUROLOGY
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differentiation of Embryonic Stem Cells into Oligodendrocyte Precursors
- (2010) Peng Jiang et al. Jove-Journal of Visualized Experiments
- MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis
- (2009) Changsheng Du et al. NATURE IMMUNOLOGY
- Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE
- (2009) Mauricio F Farez et al. NATURE IMMUNOLOGY
- Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis
- (2008) Hideki Garren et al. ANNALS OF NEUROLOGY
- Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy
- (2008) Evan Sloane et al. BRAIN BEHAVIOR AND IMMUNITY
- Schwann Cell Transplantation for CNS Repair
- (2008) R. Matsas et al. CURRENT MEDICINAL CHEMISTRY
- IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis
- (2008) E Butti et al. GENE THERAPY
- Neuroprotective Effect of Transplanted Human Embryonic Stem Cell-Derived Neural Precursors in an Animal Model of Multiple Sclerosis
- (2008) Michal Aharonowiz et al. PLoS One
- Mechanisms of Disease: sodium channels and neuroprotection in multiple sclerosis—current status
- (2008) Stephen G Waxman Nature clinical practice. Neurology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started